🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establish a follow-up management system for pediatric heart failure and a r...
Status
Unknown
Location
Fuwai hospital
Start Date
2022-01-01
Trial ID
NCT06345521
Treatments Being Tested
This is a Phase 1, open-label, randomized, PK and safety study in a maximum...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2018-11-26
Trial ID
NCT03691584
Treatments Being Tested
The goal of this clinical investigation is to asses the safety and efficacy...
Status
Unknown
Location
CHU de Caen
Start Date
2024-03-11
Trial ID
NCT06024135
Treatments Being Tested
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
The objective of this study is to determine the safety and effectiveness of...
Status
Recruiting
Location
Loma Linda University
Start Date
2022-06-16
Trial ID
NCT05438732
Treatments Being Tested
Hemolytic and uremic syndrome (HUS) is a clinic-biological syndrome related...
Status
Recruiting
Location
Tenon Hospital
Start Date
2023-11-09
Trial ID
NCT05726916
Treatments Being Tested
In this End Stage Renal Disease (ESRD) patients who need Erythropoietin (ep...
Status
Terminated
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01555515
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
This is a Phase 1, open-label, single-dose study of the safety, tolerabilit...
Status
Terminated
Location
University Hospital Cologne-Clinical Trial Center
Start Date
2017-05-29
Trial ID
NCT02808052
Treatments Being Tested
This study is a prospective, open-label, single-arm phase II clinical trial...
Status
Recruiting
Location
First Affiliated Hospital of Nanjing Medical Unviersity
Start Date
2024-11-14
Trial ID
NCT06895447
Treatments Being Tested